RANKL expression is increased in bone marrow stromal cells in patients with myeloma [8], [9] and may also be expressed directly by both murine and human myeloma cells [10], [11], [12], [13], [14]. This evidence concerns the gene TNFSF11 and plasma cell myeloma.